PIK3R4

gene
On this page

Also known as VPS15p150

Summary

PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4, HGNC:8982) is a protein-coding gene on chromosome 3q22.1, encoding Phosphoinositide 3-kinase regulatory subunit 4 (Q99570). Regulatory subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of…. It is a selective cancer dependency (DepMap: 38.9% of cell lines).

Predicted to enable protein serine/threonine kinase activity. Involved in several processes, including early endosome to late endosome transport; phosphatidylinositol 3-kinase/protein kinase B signal transduction; and phosphatidylinositol-3-phosphate biosynthetic process. Located in ciliary basal body; intercellular bridge; and late endosome. Part of phosphatidylinositol 3-kinase complex, class III.

Source: NCBI Gene 30849 — RefSeq curated summary.

At a glance

  • GWAS associations: 2
  • Clinical variants (ClinVar): 189 total
  • Druggable target: yes
  • Cancer dependency (DepMap): dependent in 38.9% of screened cell lines
  • MANE Select transcript: NM_014602

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:8982
Approved symbolPIK3R4
Namephosphoinositide-3-kinase regulatory subunit 4
Location3q22.1
Locus typegene with protein product
StatusApproved
AliasesVPS15, p150
Ensembl geneENSG00000196455
Ensembl biotypeprotein_coding
OMIM602610
Entrez30849

Gene structure

Transcript identifiers

Ensembl transcripts: 11 — 7 protein_coding, 2 protein_coding_CDS_not_defined, 2 retained_intron

ENST00000356763, ENST00000504834, ENST00000507330, ENST00000508273, ENST00000511760, ENST00000512362, ENST00000512430, ENST00000512677, ENST00000893859, ENST00000893860, ENST00000954554

RefSeq mRNA: 1 — MANE Select: NM_014602 NM_014602

CCDS: CCDS3067

Canonical transcript exons

ENST00000356763 — 20 exons

ExonStartEnd
ENSE00000778202130735869130736002
ENSE00000778205130728463130728684
ENSE00000778207130718389130718534
ENSE00000778208130716396130716599
ENSE00000778209130708291130708492
ENSE00000778210130706948130707135
ENSE00000778211130705561130705771
ENSE00000778212130703723130703888
ENSE00000778213130690490130690654
ENSE00001048139130733548130734130
ENSE00001078058130744486130745264
ENSE00001151964130730308130730442
ENSE00001151979130746318130746829
ENSE00001431034130678934130679485
ENSE00003473754130723414130723587
ENSE00003491621130684250130684381
ENSE00003605957130681491130681591
ENSE00003670145130680613130680721
ENSE00003672366130680977130681065
ENSE00003684151130686211130686422

Expression profiles

Bgee: expression breadth ubiquitous, 287 present calls, max score 92.88.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 18.2763 / max 238.3430, expressed in 1803 samples.

FANTOM5 promoters (4 alternative TSS)

Promoter IDTPM avgSamples expressed
4457717.55271802
445780.5468328
445750.118442
445760.058426

Top tissues by expression

295 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
right lobe of liverUBERON:000111492.88gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099192.34gold quality
adenohypophysisUBERON:000219691.93gold quality
colonic epitheliumUBERON:000039791.59gold quality
right lobe of thyroid glandUBERON:000111991.33gold quality
pituitary glandUBERON:000000791.31gold quality
Brodmann (1909) area 9UBERON:001354090.98gold quality
epithelium of nasopharynxUBERON:000195190.57gold quality
ventricular zoneUBERON:000305390.52gold quality
mucosa of transverse colonUBERON:000499190.44gold quality
left lobe of thyroid glandUBERON:000112090.39gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.14gold quality
upper lobe of left lungUBERON:000895290.01gold quality
right lungUBERON:000216789.88gold quality
tibial nerveUBERON:000132389.85gold quality
thyroid glandUBERON:000204689.76gold quality
upper lobe of lungUBERON:000894889.67gold quality
skin of abdomenUBERON:000141689.62gold quality
skin of legUBERON:000151189.53gold quality
right frontal lobeUBERON:000281089.49gold quality
liverUBERON:000210789.42gold quality
right ovaryUBERON:000211889.41gold quality
right coronary arteryUBERON:000162589.28gold quality
right adrenal glandUBERON:000123389.22gold quality
right adrenal gland cortexUBERON:003582789.18gold quality
ectocervixUBERON:001224989.15gold quality
caudate nucleusUBERON:000187389.10gold quality
corpus epididymisUBERON:000435989.07gold quality
putamenUBERON:000187489.06gold quality
right uterine tubeUBERON:000130288.94gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes7.13
E-MTAB-7249no145.09

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

41 targeting PIK3R4, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-LET-7A-3P100.0074.033932
HSA-LET-7B-3P100.0074.083913
HSA-LET-7F-1-3P100.0074.023928
HSA-MIR-98-3P100.0074.083907
HSA-MIR-4455100.0065.481587
HSA-MIR-428299.9975.366408
HSA-MIR-548P99.9872.253784
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-4789-5P99.9870.762721
HSA-MIR-1229-3P99.9766.49906
HSA-MIR-1250-3P99.9670.044038
HSA-MIR-4666A-3P99.9671.713434
HSA-MIR-335-3P99.9373.364958
HSA-MIR-381-3P99.9371.872854
HSA-MIR-30099.9271.762856
HSA-MIR-130599.9171.433443
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-153-5P99.8973.866317
HSA-MIR-450399.8571.451869
HSA-MIR-117999.7168.701040
HSA-MIR-494-3P99.7071.452795
HSA-MIR-518A-5P99.7069.012209
HSA-MIR-52799.7069.012209
HSA-MIR-7154-5P99.6970.521900
HSA-MIR-7844-5P99.5568.561428
HSA-MIR-664A-3P99.2271.082696
HSA-MIR-5583-3P99.0665.681018
HSA-MIR-605-5P98.7968.241161

Functional genomics

DepMap (CRISPR cell-line fitness): dependent in 38.9% of screened cell lines.

Literature-anchored findings (GeneRIF, showing 7)

  • hVps15, but not Ca2+/CaM, is required for the activity and regulation of hVps34 in mammalian cells (PMID:18957027)
  • A specific sub-complex containing VPS15, VPS34, Beclin 1, UVRAG and BIF-1 regulates both receptor degradation and cytokinesis, whereas ATG14L, a PI3K-III subunit involved in autophagy, is not required. (PMID:20643123)
  • High expression of PI3K core complex genes is associated with poor prognosis in chronic lymphocytic leukemia. (PMID:25840748)
  • A missense mutation in PIK3R4 (phosphoinositide 3-kinase regulatory subunit 4, named VPS15) in a family with a ciliopathy phenotype is identified. Besides being required for trafficking and autophagy, we show that VPS15 regulates primary cilium length in human fibroblasts. (PMID:27882921)
  • Both Danon Disease and glycogen storage disease type II show accumulation and altered localization of VPS15 in autophagy-incompetent fibers. However, TFEB displays a different pattern between these two lysosomal storage diseases (PMID:28102838)
  • The mutations in VPS15 are associated with cortical atrophy and epilepsy in humans. (PMID:29311744)
  • Phosphoproteomic identification of ULK substrates reveals VPS15-dependent ULK/VPS34 interplay in the regulation of autophagy. (PMID:34121209)

Cross-species orthologs

5 orthologs

OrganismSymbolGene ID
danio_reriopik3r4ENSDARG00000060469
mus_musculusPik3r4ENSMUSG00000032571
rattus_norvegicusPik3r4ENSRNOG00000013669
drosophila_melanogasterVps15FBGN0260935
caenorhabditis_elegansWBGENE00014151

Protein

Protein identifiers

Phosphoinositide 3-kinase regulatory subunit 4Q99570 (reviewed: Q99570)

Alternative names: PI3-kinase p150 subunit, Phosphoinositide 3-kinase adaptor protein

All UniProt accessions (4): D6RAC3, D6RBB7, D6RJ98, Q99570

UniProt curated annotations — full annotation on UniProt →

Function. Regulatory subunit of the PI3K complex that mediates formation of phosphatidylinositol 3-phosphate; different complex forms are believed to play a role in multiple membrane trafficking pathways: PI3KC3-C1 is involved in initiation of autophagosomes and PI3KC3-C2 in maturation of autophagosomes and endocytosis. Involved in regulation of degradative endocytic trafficking and cytokinesis, probably in the context of PI3KC3-C2.

Subunit / interactions. Component of the PI3K (PI3KC3/PI3K-III/class III phosphatidylinositol 3-kinase) complex the core of which is composed of the catalytic subunit PIK3C3, the regulatory subunit PIK3R4 and BECN1 associating with additional regulatory/auxiliary subunits to form alternative complex forms. Alternative complex forms containing a fourth regulatory subunit in a mutually exclusive manner are PI3K complex I (PI3KC3-C1) containing ATG14, and PI3K complex II (PI3KC3-C2) containing UVRAG. PI3KC3-C1 displays a V-shaped architecture with PIK3R4 serving as a bridge between PIK3C3 and the ATG14:BECN1 subcomplex. Both, PI3KC3-C1 and PI3KC3-C2, can associate with further regulatory subunits, such as RUBCN, SH3GLB1/Bif-1, AMBRA1 and NRBF2. PI3KC3-C1 probably associates with PIK3CB. Interacts with RAB7A in the presence of PIK3C3/VPS34. Interacts with NRBF2. Interacts with ARMC3.

Subcellular location. Late endosome. Cytoplasmic vesicle. Autophagosome. Membrane.

Tissue specificity. Ubiquitously expressed.

Post-translational modifications. Myristoylated. Probably autophosphorylated.

Similarity. Belongs to the protein kinase superfamily. Ser/Thr protein kinase family.

RefSeq proteins (1): NP_055417* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000719Prot_kinase_domDomain
IPR001680WD40_rptRepeat
IPR008271Ser/Thr_kinase_ASActive_site
IPR011009Kinase-like_dom_sfHomologous_superfamily
IPR011989ARM-likeHomologous_superfamily
IPR015943WD40/YVTN_repeat-like_dom_sfHomologous_superfamily
IPR016024ARM-type_foldHomologous_superfamily
IPR021133HEAT_type_2Repeat
IPR036322WD40_repeat_dom_sfHomologous_superfamily
IPR045162Vps15-likeFamily
IPR055231PIK3R4-like_middleDomain

Pfam: PF00069, PF00400, PF22956

Catalyzed reactions (Rhea), 2 shown:

  • L-seryl-[protein] + ATP = O-phospho-L-seryl-[protein] + ADP + H(+) (RHEA:17989)
  • L-threonyl-[protein] + ATP = O-phospho-L-threonyl-[protein] + ADP + H(+) (RHEA:46608)

UniProt features (148 total): helix 57, strand 45, turn 11, repeat 10, sequence variant 8, modified residue 5, region of interest 2, binding site 2, sequence conflict 2, initiator methionine 1, chain 1, compositionally biased region 1, active site 1, domain 1, lipid moiety-binding region 1

Structure

Experimental structures (PDB)

14 structures.

PDBMethodResolution (Å)
9MHFELECTRON MICROSCOPY2.73
9RX5ELECTRON MICROSCOPY3.15
9MHGELECTRON MICROSCOPY3.2
9RX6ELECTRON MICROSCOPY3.52
13BVELECTRON MICROSCOPY3.77
9RX8ELECTRON MICROSCOPY3.87
9RX9ELECTRON MICROSCOPY3.99
9RXAELECTRON MICROSCOPY4
9RXBELECTRON MICROSCOPY4.03
9MHHELECTRON MICROSCOPY4.5
9C82ELECTRON MICROSCOPY6.84
7BL1ELECTRON MICROSCOPY9.8
9S47ELECTRON MICROSCOPY9.88
8SOR

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q99570-F178.470.33

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Catalytic / active sites (1): 148 (proton acceptor)

Ligand- & substrate-binding residues (2): 32–40; 53

Post-translational modifications (6): 808, 813, 853, 865, 1316, 2

Function

Pathways and Gene Ontology

Reactome pathways

12 pathways

IDPathway
R-HSA-109704PI3K Cascade
R-HSA-1632852Macroautophagy
R-HSA-1660514Synthesis of PIPs at the Golgi membrane
R-HSA-1660516Synthesis of PIPs at the early endosome membrane
R-HSA-1660517Synthesis of PIPs at the late endosome membrane
R-HSA-168138Toll Like Receptor 9 (TLR9) Cascade
R-HSA-5668599RHO GTPases Activate NADPH Oxidases
R-HSA-9679504Translation of Replicase and Assembly of the Replication Transcription Complex
R-HSA-9694676Translation of Replicase and Assembly of the Replication Transcription Complex
R-HSA-9705671SARS-CoV-2 activates/modulates innate and adaptive immune responses
R-HSA-983170Antigen Presentation: Folding, assembly and peptide loading of class I MHC
R-HSA-9920951Dengue virus modulates apoptosis

MSigDB gene sets: 251 (showing top): E2F_Q4_01, REACTOME_SIGNALING_BY_INSULIN_RECEPTOR, GOBP_REGULATION_OF_AUTOPHAGY, GOBP_PHOSPHOLIPID_METABOLIC_PROCESS, REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_PHOSPHATIDYLINOSITOL_METABOLIC_PROCESS, GOBP_LYSOSOMAL_TRANSPORT, GU_PDEF_TARGETS_DN, REACTOME_ADAPTIVE_IMMUNE_SYSTEM, GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, REACTOME_ANTIGEN_PRESENTATION_FOLDING_ASSEMBLY_AND_PEPTIDE_LOADING_OF_CLASS_I_MHC, REACTOME_CLASS_I_MHC_MEDIATED_ANTIGEN_PROCESSING_PRESENTATION, GOBP_PROTEIN_TARGETING, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_VACUOLAR_TRANSPORT

GO Biological Process (15): pexophagy (GO:0000425), protein phosphorylation (GO:0006468), protein targeting to lysosome (GO:0006622), protein targeting to vacuole (GO:0006623), regulation of autophagy (GO:0010506), regulation of macroautophagy (GO:0016241), regulation of cytokinesis (GO:0032465), receptor catabolic process (GO:0032801), phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092), cellular response to glucose starvation (GO:0042149), phosphatidylinositol 3-kinase/protein kinase B signal transduction (GO:0043491), early endosome to late endosome transport (GO:0045022), late endosome to vacuole transport (GO:0045324), autophagosome maturation (GO:0097352), macroautophagy (GO:0016236)

GO Molecular Function (8): protein kinase activity (GO:0004672), protein serine/threonine kinase activity (GO:0004674), ATP binding (GO:0005524), protein serine kinase activity (GO:0106310), nucleotide binding (GO:0000166), protein binding (GO:0005515), kinase activity (GO:0016301), transferase activity (GO:0016740)

GO Cellular Component (18): late endosome (GO:0005770), autophagosome (GO:0005776), cytosol (GO:0005829), cilium (GO:0005929), axoneme (GO:0005930), microtubule cytoskeleton (GO:0015630), membrane (GO:0016020), phagocytic vesicle membrane (GO:0030670), phosphatidylinositol 3-kinase complex, class III, type I (GO:0034271), phosphatidylinositol 3-kinase complex, class III, type II (GO:0034272), phosphatidylinositol 3-kinase complex, class III (GO:0035032), ciliary basal body (GO:0036064), intercellular bridge (GO:0045171), nucleus-vacuole junction (GO:0071561), cytoplasm (GO:0005737), endosome (GO:0005768), cytoskeleton (GO:0005856), cytoplasmic vesicle (GO:0031410)

Reactome top-level categories

Rollup of top-10 pathways:

CategoryPathways
PI Metabolism3
IRS-mediated signalling1
Autophagy1
Toll-like Receptor Cascades1
RHO GTPase Effectors1
SARS-CoV-1 Infection1
Early SARS-CoV-2 Infection Events1
SARS-CoV-2-host interactions1
Class I MHC mediated antigen processing & presentation1
Dengue Virus-Host Interactions1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure5
macroautophagy3
cytoplasm3
vacuolar transport2
autophagy2
protein kinase activity2
cytoskeleton2
phosphatidylinositol 3-kinase complex, class III2
autophagy of peroxisome1
phosphorylation1
protein modification process1
protein targeting to vacuole1
lysosomal transport1
protein localization to lysosome1
protein targeting1
intracellular protein transport1
protein localization to vacuole1
establishment of protein localization to vacuole1
regulation of catabolic process1
regulation of autophagy1
cytokinesis1
regulation of cell cycle process1
regulation of cell division1
macromolecule catabolic process1
receptor metabolic process1
phosphatidylinositol phosphate biosynthetic process1
cellular response to starvation1
intracellular signaling cassette1
vesicle-mediated transport between endosomal compartments1
intercellular transport1
vesicle-mediated transport1
protein-containing complex disassembly1
autophagosome assembly1
kinase activity1
phosphotransferase activity, alcohol group as acceptor1
catalytic activity, acting on a protein1
adenyl ribonucleotide binding1
purine ribonucleoside triphosphate binding1
nucleoside phosphate binding1
heterocyclic compound binding1

Protein interactions and networks

STRING

2004 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
PIK3R4ATG14Q6ZNE5999
PIK3R4PIK3C3Q8NEB9999
PIK3R4UVRAGQ9P2Y5999
PIK3R4BECN1Q14457999
PIK3R4AMBRA1Q9C0C7996
PIK3R4NRBF2Q96F24995
PIK3R4RUBCNQ92622980
PIK3R4BECN2A8MW95978
PIK3R4SH3GLB1Q9Y371945
PIK3R4ATG7O95352930
PIK3R4ATG13O75143916
PIK3R4ATG5Q9H1Y0893
PIK3R4ATG16L1Q676U5880
PIK3R4BNIP1Q12981876
PIK3R4RB1CC1Q8TDY2872

IntAct

139 interactions, top by confidence:

ABTypeScore
ATG14BECN1psi-mi:“MI:0915”(physical association)0.980
ATG14BECN1psi-mi:“MI:0914”(association)0.980
UVRAGBECN1psi-mi:“MI:0915”(physical association)0.970
BECN1PIK3C3psi-mi:“MI:0915”(physical association)0.970
UVRAGBECN1psi-mi:“MI:0914”(association)0.970
BECN1PIK3C3psi-mi:“MI:0914”(association)0.970
PIK3C3BECN1psi-mi:“MI:0914”(association)0.970
ATG14PIK3C3psi-mi:“MI:0914”(association)0.950
RUBCNBECN1psi-mi:“MI:0914”(association)0.920
NRBF2PIK3R4psi-mi:“MI:0915”(physical association)0.920
NRBF2BECN1psi-mi:“MI:0914”(association)0.860
NRBF2PIK3C3psi-mi:“MI:0914”(association)0.850
PIK3C3NRBF2psi-mi:“MI:0914”(association)0.850

BioGRID (196): PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-RNA), PIK3R4 (Affinity Capture-RNA), PIK3R4 (Affinity Capture-Western), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Co-fractionation), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS), PIK3R4 (Affinity Capture-MS)

ESM2 similar proteins: A0A0R4IB93, A0A2R8QPS5, A1Z7K9, A2QW83, A4RF51, A5DAD0, A6QR55, B0X2V9, F6V6I0, F6Z5C0, O13046, O17468, P0C0R5, P0C581, P35123, P53015, Q05B30, Q09798, Q0J7U6, Q0WV90, Q10NY2, Q13107, Q1E873, Q20059, Q27GK7, Q4WHP6, Q5NBT9, Q5R4F4, Q5R9I3, Q5RCD3, Q5ZMV9, Q6CMN5, Q6DIP5, Q754X1, Q7ZVL2, Q7ZX22, Q84JM4, Q8R5H1, Q8VD65, Q94AI7

Diamond homologs: A8X5H5, F4ICB6, F4JY12, G4NH08, O14132, O42900, P0C0R5, P18265, P18266, P18431, P22219, P43292, P49840, P49841, P51136, P51137, P54665, P54685, Q00534, Q09499, Q10452, Q12222, Q2NL51, Q2V419, Q38774, Q388M1, Q3S406, Q40518, Q54XJ4, Q5R9I3, Q5YJC2, Q64261, Q6BRY2, Q6CCB0, Q6FRH8, Q6I5Y0, Q6ZAG3, Q7XQP4, Q8SW92, Q8VD65

SIGNOR signaling

6 interactions.

AEffectBMechanism
NRBF2“down-regulates activity”PIK3R4binding
PIK3R4up-regulatesPIK3C3binding
RAB5A“up-regulates activity”PIK3R4binding
PIK3R4“up-regulates activity”PIK3C3binding
PIK3R4“form complex”“Vps34 Complex I”binding
PIK3R4“form complex”“Vps34 Complex II”binding

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 134 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Antigen Presentation: Folding, assembly and peptide loading of class I MHC522.1×3e-04
Intrinsic Pathway for Apoptosis516.4×8e-04
Macroautophagy1114.3×1e-07
SARS-CoV-2-host interactions810.7×2e-04
Translocation of SLC2A4 (GLUT4) to the plasma membrane610.4×1e-03
Autophagy610.0×1e-03
SARS-CoV-1-host interactions59.9×4e-03
SARS-CoV-1 Infection69.6×1e-03

GO biological processes:

GO termPartnersFoldFDR
autophagosome maturation721.6×8e-06
autophagosome assembly917.7×7e-07
mitophagy616.7×3e-04
cellular response to glucose starvation514.8×2e-03
macroautophagy510.6×9e-03
autophagy87.7×1e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

189 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance153
Likely benign5
Benign6

Top pathogenic / likely-pathogenic (0)

SpliceAI

3192 predictions. Top by Δscore:

VariantEffectΔscore
3:130679497:T:TCacceptor_gain1.0000
3:130680608:AGTAC:Adonor_loss1.0000
3:130680609:GTA:Gdonor_loss1.0000
3:130680612:C:CAdonor_loss1.0000
3:130680720:ACC:Aacceptor_loss1.0000
3:130680722:CTAGG:Cacceptor_loss1.0000
3:130680723:T:Aacceptor_loss1.0000
3:130681067:T:Cacceptor_gain1.0000
3:130684245:CTTAC:Cdonor_loss1.0000
3:130684246:TTACC:Tdonor_loss1.0000
3:130684248:ACCT:Adonor_loss1.0000
3:130684249:C:CGdonor_loss1.0000
3:130684249:CCTG:Cdonor_gain1.0000
3:130684377:TGTAC:Tacceptor_gain1.0000
3:130684379:TAC:Tacceptor_gain1.0000
3:130684379:TACC:Tacceptor_loss1.0000
3:130684380:AC:Aacceptor_gain1.0000
3:130684381:CC:Cacceptor_gain1.0000
3:130684382:C:CCacceptor_gain1.0000
3:130684382:C:Tacceptor_gain1.0000
3:130684382:CTTA:Cacceptor_loss1.0000
3:130684383:T:Cacceptor_gain1.0000
3:130684383:T:TCacceptor_gain1.0000
3:130690485:GATA:Gdonor_loss1.0000
3:130690486:ATAC:Adonor_loss1.0000
3:130690487:TACC:Tdonor_loss1.0000
3:130690488:ACC:Adonor_loss1.0000
3:130690489:CCTG:Cdonor_gain1.0000
3:130690531:AGAAG:Adonor_gain1.0000
3:130690650:TAGAT:Tacceptor_gain1.0000

AlphaMissense

8975 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
3:130679323:A:GW1357R1.000
3:130679323:A:TW1357R1.000
3:130679338:C:AG1352W1.000
3:130680717:A:GW1268R1.000
3:130680717:A:TW1268R1.000
3:130681562:A:GW1213R1.000
3:130681562:A:TW1213R1.000
3:130684341:G:CF1172L1.000
3:130684341:G:TF1172L1.000
3:130684342:A:CF1172C1.000
3:130684342:A:GF1172S1.000
3:130684343:A:CF1172V1.000
3:130684343:A:GF1172L1.000
3:130684343:A:TF1172I1.000
3:130684344:C:AR1171S1.000
3:130684344:C:GR1171S1.000
3:130684345:C:AR1171M1.000
3:130684345:C:GR1171T1.000
3:130684350:G:CD1169E1.000
3:130684350:G:TD1169E1.000
3:130684351:T:AD1169V1.000
3:130684351:T:CD1169G1.000
3:130684351:T:GD1169A1.000
3:130684352:C:GD1169H1.000
3:130684355:A:GW1168R1.000
3:130684355:A:TW1168R1.000
3:130684381:C:TG1159D1.000
3:130686219:A:GL1156P1.000
3:130686289:A:GW1133R1.000
3:130686289:A:TW1133R1.000

dbSNP variants (sampled 300 via entrez): RS1000021511 (3:130685019 A>G), RS1000101900 (3:130704703 T>C), RS1000128103 (3:130732073 G>C,T), RS1000165057 (3:130703167 G>T), RS1000182024 (3:130742308 A>C), RS1000280003 (3:130697552 G>C,T), RS1000282514 (3:130742551 G>A,C), RS1000291649 (3:130690346 A>C), RS1000325158 (3:130711701 A>G), RS1000361252 (3:130724980 T>C), RS1000392843 (3:130737077 A>G), RS1000473057 (3:130739202 G>A,C), RS1000489583 (3:130729148 A>C), RS1000526314 (3:130743693 C>T), RS1000594975 (3:130691568 T>C)

Disease associations

OMIM: gene MIM:602610 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

2 associations (top):

StudyTraitp-value
GCST009091_5Abdominal aortic calcification levels5.000000e-07
GCST010002_439Refractive error5.000000e-11

EFO canonical traits (1, from GWAS)

EFO IDTrait name
EFO:0010272abdominal aortic calcification measurement

Drugs & pharmacology

Drug and pharmacology data

Is drug target: yes

ChEMBL targets (2): CHEMBL2189144 (SINGLE PROTEIN), CHEMBL5483084 (PROTEIN COMPLEX)

PharmGKB: 1 entry (VIP=true, CPIC=false)

GtoPdb / IUPHAR curated pharmacology

(IUPHAR/BPS Guide to Pharmacology — expert-curated)

Target class: enzyme — Phosphatidylinositol kinases

ChEMBL bioactivities

2 potent at pChembl≥5 of 3 total, top 1 by pChembl (potency: 10 = 0.1 nM, 6 = 1 µM).

pChemblTypeValueUnitMolecule
7.60IC5025nMCHEMBL3913746

PubChem BioAssay actives

2 with measured affinity, of 6 total; 1 most potent distinct compounds. Largely complementary to BindingDB; screening values are coarse (µM, 4 dp), so sub-nM hits tie at the floor.

CompoundAssayTypeValueUnit
1-[[5-[2-[(2-chloro-4-pyridinyl)amino]pyrimidin-4-yl]-4-(cyclopropylmethyl)pyrimidin-2-yl]amino]-2-methylpropan-2-ol2017597: Inhibition of recombinant human Vps34-Vps15 complex expressed in insect cells assessed as reduction in PtdIns phosphorylation in presence of gamma32P-ATP by radioactive assayic500.0250uM

CTD chemical–gene interactions

28 total (human), top 28 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Adecreases expression, decreases methylation2
aristolochic acid Idecreases expression1
FR900359affects phosphorylation1
triphenyl phosphateaffects expression1
decabromobiphenyl etherdecreases expression1
zinc chlorideincreases expression1
sodium arseniteaffects binding, increases reaction1
tetrabromobisphenol Adecreases expression1
mesotrioneaffects methylation, increases abundance1
abrinedecreases expression1
2,2’,4,4’-tetrabromodiphenyl etherdecreases expression1
pentabrominated diphenyl ether 100decreases expression1
hexabrominated diphenyl ether 153decreases expression1
jinfukangdecreases expression1
Sunitinibincreases expression1
Air Pollutants, Occupationaldecreases expression1
Atrazinedecreases expression1
Doxorubicindecreases expression1
Herbicidesaffects methylation, increases abundance1
Ivermectindecreases expression1
Mercuryincreases expression1
Nickeldecreases expression1
Piroxicamdecreases expression1
Ribonucleotidesaffects binding1
Thiramdecreases expression1
Zincincreases expression1
Cyclosporinedecreases expression1
Copper Sulfatedecreases expression1

ChEMBL screening assays

6 unique, capped per target: 6 binding

Representative assays (with source publication via chembl_document):

Assay IDTypeDescriptionSource paper
CHEMBL2211984BindingInhibition of PIK3R4Discovery of 5-(2-amino-[1,2,4]triazolo[1,5-a]pyridin-7-yl)-N-(tert-butyl)pyridine-3-sulfonamide (CZC24758), as a potent, orally bioavailable and selective inhibitor of PI3K for the treatment of inflammatory disease. — Bioorg Med Chem Lett

Cellosaurus cell lines

4 cell lines: 4 cancer cell line

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_B7YSAbcam Raji PIK3R4 KOCancer cell lineMale
CVCL_B9ZHAbcam THP-1 PIK3R4 KOCancer cell lineMale
CVCL_C7B6Abcam PC-3 PIK3R4 KOCancer cell lineMale
CVCL_E3KCHeLa S3 PIK3R4 KO clone #89Cancer cell lineFemale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.